99 related articles for article (PubMed ID: 1996625)
1. IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection.
Lemmey AB; Martin AA; Read LC; Tomas FM; Owens PC; Ballard FJ
Am J Physiol; 1991 Feb; 260(2 Pt 1):E213-9. PubMed ID: 1996625
[TBL] [Abstract][Full Text] [Related]
2. Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats.
Tomas FM; Knowles SE; Owens PC; Read LC; Chandler CS; Gargosky SE; Ballard FJ
J Endocrinol; 1991 Jan; 128(1):97-105. PubMed ID: 1999680
[TBL] [Abstract][Full Text] [Related]
3. Truncated and native insulinlike growth factor I enhance mucosal adaptation after jejunoileal resection.
Vanderhoof JA; McCusker RH; Clark R; Mohammadpour H; Blackwood DJ; Harty RF; Park JH
Gastroenterology; 1992 Jun; 102(6):1949-56. PubMed ID: 1375179
[TBL] [Abstract][Full Text] [Related]
4. IGF-I and its variant, des-(1-3)IGF-I, enhance growth in rats with reduced renal mass.
Martin AA; Tomas FM; Owens PC; Knowles SE; Ballard FJ; Read LC
Am J Physiol; 1991 Oct; 261(4 Pt 2):F626-33. PubMed ID: 1928375
[TBL] [Abstract][Full Text] [Related]
5. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I.
Tomas FM; Knowles SE; Owens PC; Read LC; Chandler CS; Gargosky SE; Ballard FJ
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):547-54. PubMed ID: 1710892
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.
Tomas FM; Knowles SE; Owens PC; Chandler CS; Francis GL; Ballard FJ
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):781-6. PubMed ID: 7683875
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats.
Tomas FM; Knowles SE; Owens PC; Chandler CS; Francis GL; Read LC; Ballard FJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):91-7. PubMed ID: 1371669
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I and its variant, des(1-3)IGF-I, improve nitrogen balance and food utilization in rats with renal failure.
Martin AA; Tomas FM; Ballard FJ; Read LC
Miner Electrolyte Metab; 1992; 18(2-5):264-8. PubMed ID: 1465072
[TBL] [Abstract][Full Text] [Related]
9. Effects of insulin-like growth factor-I peptides in rats with acute renal failure.
Martin AA; Gillespie CM; Moore L; Ballard FJ; Read LC
J Endocrinol; 1994 Jan; 140(1):23-32. PubMed ID: 8138750
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I prevents gut atrophy and maintains intestinal integrity in septic rats.
Chen K; Okuma T; Okamura K; Tabira Y; Kaneko H; Miyauchi Y
JPEN J Parenter Enteral Nutr; 1995; 19(2):119-24. PubMed ID: 7609275
[TBL] [Abstract][Full Text] [Related]
11. Enhanced potency of truncated insulin-like growth factor-I (des(1-3)IGF-I) relative to IGF-I in lit/lit mice.
Gillespie C; Read LC; Bagley CJ; Ballard FJ
J Endocrinol; 1990 Dec; 127(3):401-5. PubMed ID: 2280209
[TBL] [Abstract][Full Text] [Related]
12. Treatment with IGF-I peptides improves function of the remnant gut following small bowel resection in rats.
Lemmey AB; Ballard FJ; Martin AA; Tomas FM; Howarth GS; Read LC
Growth Factors; 1994; 10(4):243-52. PubMed ID: 7803042
[TBL] [Abstract][Full Text] [Related]
13. Systemic infusion of IGF-I or LR(3)IGF-I stimulates visceral organ growth and proliferation of gut tissues in suckling rats.
Steeb CB; Shoubridge CA; Tivey DR; Read LC
Am J Physiol; 1997 Mar; 272(3 Pt 1):G522-33. PubMed ID: 9124573
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I (IGF-I) analogue, LR(3)IGF-I, ameliorates the loss of body weight but not of skeletal muscle during food restriction.
Tomas FM
Growth Horm IGF Res; 2001 Apr; 11(2):92-103. PubMed ID: 11472075
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats.
Cool JC; Dyer JL; Xian CJ; Butler RN; Geier MS; Howarth GS
Growth Horm IGF Res; 2005 Feb; 15(1):72-82. PubMed ID: 15701575
[TBL] [Abstract][Full Text] [Related]
16. Conjoint IGF-I and insulin infusion shows diverse interactive effects in diabetic rats.
Tomas FM; Knowles SE; Owens PC; Burgoyne JL; Chandler CS; Ballard FJ
Diabetes; 1996 Feb; 45(2):170-7. PubMed ID: 8549861
[TBL] [Abstract][Full Text] [Related]
17. Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection.
Tomas FM; Lemmey AB; Read LC; Ballard FJ
J Endocrinol; 1996 Jul; 150(1):77-84. PubMed ID: 8708565
[TBL] [Abstract][Full Text] [Related]
18. Continuous 14 day infusion of IGF-II increases the growth of normal female rats, but exhibits a lower potency than IGF-I.
Conlon MA; Francis GL; Tomas FM; Wallace JC; Howarth GS; Ballard FJ
J Endocrinol; 1995 Jan; 144(1):91-8. PubMed ID: 7534330
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats.
Read LC; Tomas FM; Howarth GS; Martin AA; Edson KJ; Gillespie CM; Owens PC; Ballard FJ
J Endocrinol; 1992 Jun; 133(3):421-31. PubMed ID: 1613443
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 has beneficial effects, whereas growth hormone has limited effects on postoperative protein metabolism, gut integrity, and splenic weight in rats with chronic mild liver injury.
Inaba T; Saito H; Fukushima R; Hashiguchi Y; Lin MT; Inoue T; Fukatsu K; Muto T; Oka T; Takenaka A; Takahashi S; Noguchi T
JPEN J Parenter Enteral Nutr; 1997; 21(2):55-62. PubMed ID: 9084006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
